Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Saudi Med J ; 38(4): 381-390, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28397944

RESUMO

OBJECTIVES: To measure prevalence of vitamin D deficiency in Saudi Arabia, unveil the life style, nutritional habits and status, as well as identify the potential risk factors. Method: A school-based survey targeting Saudi school students and employees was conducted during the  period from 2013 to 2014 using multistage cluster random sample in Central, Western and Eastern regions. The prevalence of vitamin D deficiency and difference between various population subgroups were calculated. Logistic regression analysis was used to determine the predictors of potential risk factors. Results: Prevalence of vitamin D deficiency was 49.5% in students and 44% in employees. Life style was not adequate to protect against vitamin D depletion. Unhealthy nutritional habits were widespread, some manifested in childhood while others manifested later in life. Living in the Eastern region, females, 16-19 years of age, low economic class, obese and lack of omega 3 supplements were risk factors in students. Employees living in the Eastern region, females, middle-income class, carbonated soft drink consumers, and lack of multivitamin supplements were at higher risk. Conclusion: There is a need for a health awareness program using evidence-based recommendations. Screening for early detection and correction of the condition should be proposed to be part of the national health strategy. There is need for identifying the burden of vitamin D deficiency on other diseases to control and improve the prognosis of these conditions.


Assuntos
Deficiência de Vitamina D/epidemiologia , Adolescente , Adulto , Fatores Etários , Bebidas Gaseificadas/efeitos adversos , Criança , Estudos Transversais , Comportamento Alimentar , Feminino , Humanos , Estilo de Vida , Masculino , Obesidade/diagnóstico , Prevalência , Análise de Regressão , Fatores de Risco , Arábia Saudita/epidemiologia , Fatores Socioeconômicos , Inquéritos e Questionários , Vitamina D/sangue , Deficiência de Vitamina D/sangue , Vitaminas/administração & dosagem , Adulto Jovem
2.
Lab Hematol ; 16(3): 53-73, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20858588

RESUMO

Both stem cell and gene therapy research are currently the focus of intense research in institutions and companies around the world. Both approaches hold great promise by offering radical new and successful ways of treating debilitating and incurable diseases effectively. Gene therapy is an approach to treat, cure, or ultimately prevent disease by changing the pattern of gene expression. It is mostly experimental, but a number of clinical human trials have already been conducted. Gene therapy can be targeted to somatic or germ cells; the most common vectors are viruses. Scientists manipulate the viral genome and thus introduce therapeutic genes to the target organ. Viruses, in this context, can cause adverse events such as toxicity, immune and inflammatory responses, as well as gene control and targeting issues. Alternative modalities being considered are complexes of DNA with lipids and proteins. Stem cells are primitive cells that have the capacity to self renew as well as to differentiate into 1 or more mature cell types. Pluripotent embryonic stem cells derived from the inner cell mass can develop into more than 200 different cells and differentiate into cells of the 3 germ cell layers. Because of their capacity of unlimited expansion and pluripotency, they are useful in regenerative medicine. Tissue or adult stem cells produce cells specific to the tissue in which they are found. They are relatively unspecialized and predetermined to give rise to specific cell types when they differentiate. The current review provides a summary of our current knowledge of stem cells and gene therapy as well as their clinical implications and related therapeutic options.


Assuntos
Células-Tronco Adultas/fisiologia , Células-Tronco Embrionárias/fisiologia , Terapia Genética/métodos , Transplante de Células-Tronco/métodos , Células-Tronco Adultas/citologia , Células-Tronco Embrionárias/citologia , Técnicas de Transferência de Genes , Vetores Genéticos , Humanos
3.
J Ayub Med Coll Abbottabad ; 22(3): 100-5, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-22338430

RESUMO

BACKGROUND: There is a dire need in the Arab world and Middle Eastern countries to reform the higher education, research policy and planning for improving the quality to meet the needs of modern society. The impact factor (IF) was developed in the 1960s by Eugene Garfield of the Institute for Scientific Information (ISI) in the USA. It has been extensively used for more than 40 years. The SCImago Journal Rank (SJR) indicator belongs to this new family of indicators based on eigenvector centrality was introduced since 2007. The SJR indicator is a size-independent metric aimed at measuring the current 'average prest (se text) per paper' of journals for use in research evaluation processes. METHODS: We present the status o the biomedical scientific research in the Middle Eastern countries through the newly developed SJR indicator showing some of the proposed ways that clearly can be applied for enhancing and development of that field in the Middle Eastern countries. RESULTS: During the period from 1996 to 2008, Northern America, Western Europe and Asiatic region are the major contributors of the scientific research Worldwide. In the Middle East, the prominent two main Arab countries are Egypt and Saudi Arabia, nevertheless, they need more planned strategies for optimal contribution to their Middle East, Arab region and the World, despite the tangible achievements of the Arab states in the higher education and scientific research during the last decade. CONCLUSION: The SJR is seemingly satisfactory for ranking the countries for their scientific contribution and impact.


Assuntos
Pesquisa Biomédica , Fator de Impacto de Revistas , Mundo Árabe , Humanos , Oriente Médio
4.
Egypt J Immunol ; 16(1): 71-81, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20726324

RESUMO

Dendritic cells (DC) are professional antigen presenting cells expressing MHC class II, derived from a common marrow precursor. They are motile, diffused and have a spidery shape with many long cytoplasmic processes. The aim of this project was to test the hypothesis that cellular injury induces the activation and functional maturation of DC. To test the effects of injury on DC activation, immature DCs were used as substrate for DC activation assays. They were obtained from their precursor in peripheral blood mononuclear cells (PBMNCs) by culturing them GM-CSF and IL-4. Expression of surface B7 was measured by immunofluorescence and flowcytometry. beta- chemokines were used as potential injury mediators, including: RANTES, MIP-1alpha, MIP-1beta, MCP-1, -2, -3 and -4, as well as other inflammatory cytokines such as TNF-alpha and IL-1. They were screened on immature DCs to examine whether or not they modulate B7-1 and B7-2. A model of cellular injury was established to investigate whether the injured parenchymal cells deliver signals to initiate DC activation or upregulation of B7-1/B7-2 by release of soluble mediators. H2O2 was used as an injury mediator to injure renal tubular epithelial cells (RTECs). RANTES, MIP-1alpha and MIP-1beta upregulated B7-1. MCP-1, -2, -3 and -4 downregulated the expression of HLA-DR greatly. Furthermore, MCP-1, -2, -3 and -4 upregulated B7.2, while and -4 and MCP2 upregulated B7.1. We observed that immature DCs could not be readily stimulated with chemokines and pro-inflammatory cytokines IL-1 and TNF-alpha unless GM-CSF and IL4 were used continuously. The supernatant of injured renal epithelial cells had an effect on DC activation. These findings may explain the role of DCs as a link between the innate and the adaptive immune response, as well as being an active participant in determining the outcome of an antigen encounter.


Assuntos
Quimiocinas/imunologia , Células Dendríticas/imunologia , Regulação da Expressão Gênica/imunologia , Leucócitos Mononucleares/imunologia , Modelos Imunológicos , Antígeno B7-1/imunologia , Antígeno B7-2/imunologia , Regulação da Expressão Gênica/efeitos dos fármacos , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Humanos , Interleucina-4/farmacologia , Fator de Necrose Tumoral alfa/farmacologia
5.
Saudi Med J ; 28(7): 1119-21, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17603723

RESUMO

In chronic myeloid leukemia (CML) proliferation is increased and resistance to apoptosis has been proposed as a mechanism accounting for myeloid cell expansion. There is still controversy on whether apoptosis plays an important role in the regulation of myelopoiesis. This study aims to investigate whether apoptosis-related proteins play a role in the evolution of CML and to identify, the relationship between Fas, p53 and apoptosis protease activating factor (Apaf-1) in CML. We found increased p53 and Apaf-1 messenger ribonucleic acid (mRNA) in patients with CML. However, one patient, who had a p53 point mutation, showed a massive elevation of p53 mRNA during blast crisis yet, conversely, a considerable reduction in Apaf-1 mRNA and Fas mRNA. Our results show an in-vivo linkage between Fas, p53 and Apaf-1 transcription regulation. This suggests that key genes involved in apoptosis are also involved in CML disease progression.


Assuntos
Fator Apoptótico 1 Ativador de Proteases/genética , Leucemia Mielogênica Crônica BCR-ABL Positiva/genética , Proteína Supressora de Tumor p53/genética , Receptor fas/genética , Apoptose , Fator Apoptótico 1 Ativador de Proteases/análise , Progressão da Doença , Humanos , Leucemia Mielogênica Crônica BCR-ABL Positiva/patologia , Mutação Puntual , Proteína Supressora de Tumor p53/análise , Receptor fas/análise
6.
Yale J Biol Med ; 78(1): 25-36, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16197727

RESUMO

OBJECTIVES: CD34+ cells and colony forming unit-granulocyte and macrophage (CFU-GM) from human bone marrow were used to investigate the role of Fas/FasL system in the regulation of myelopoiesis. METHODS: Fas and FasL expression in CD34+ cells and in day 14 CFU-GM were measured by RT-PCR and immunofluorescence respectively. The functional assays for the CFU-GM were measured by a standard colony assay and the proliferative capacity of CFU-GM was measured by replating the primary colony and observing the secondary colony formation. Human marrow cells were treated with IETD (caspase-8 inhibitor) or anti-Fas CH-11 Mab. RESULTS: Treatment with the CFU-GM with IETD significantly increased, the proliferative capacity, while anti-Fas CH-11 Mab markedly reduced it. Fas and FasL expression were demonstrated using RT-PCR and immunofluorescence respectively. CONCLUSION: Fas, FasL, and caspase activation are likely to play an important role in the regulation of myelopoiesis.


Assuntos
Antígenos CD34/metabolismo , Apoptose/fisiologia , Células-Tronco Hematopoéticas/citologia , Células-Tronco Hematopoéticas/metabolismo , Glicoproteínas de Membrana/metabolismo , Mielopoese/fisiologia , Receptores do Fator de Necrose Tumoral/metabolismo , Fatores de Necrose Tumoral/metabolismo , Células da Medula Óssea/citologia , Células da Medula Óssea/metabolismo , Proliferação de Células , Células Cultivadas , Proteína Ligante Fas , Homeostase/fisiologia , Humanos , Receptor fas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...